SCHEMBL16130804

SCHEMBL16130804

COCCC1CC1CCCC(C)C

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.32
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16130294 0.82 LMNA (0.33) LMNA
SCHEMBL10119375 0.73 ALDH1A1 (0.30)
SCHEMBL10141168 0.73
SCHEMBL24205744 0.72 HTR2C (0.32) LMNA
SCHEMBL17385263 0.71 HTR2C (0.39)
SCHEMBL90561 0.70
SCHEMBL21075853 0.69
Ammonia Solution, Strong SCHEMBL28693126 0.68 ALOX5 (0.50) LMNA
SCHEMBL9634314 0.68
SCHEMBL13590013 0.67 LMNA (0.39) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846638-B2 Macrocyclic nucleoside phosphoramidate derivatives ENANTA PHARMACEUTICALS, INC. (US) 2014-09-30 US disclosed